Sientra, Inc. (SIEN) News
Filter SIEN News Items
SIEN News Results
|Loading, please wait...|
SIEN News Highlights
- SIEN's 30 day story count now stands at 2.
- Over the past 3 days, the trend for SIEN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- LI and LU are the most mentioned tickers in articles about SIEN.
Latest SIEN News From Around the Web
Below are the latest news stories about Sientra Inc that investors may wish to consider to help them evaluate SIEN as an investment opportunity.
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Investment company Salomon & Ludwin, LLC (Current Portfolio) buys Eli Lilly and Co, AbbVie Inc, Abbott Laboratories, Hasbro Inc, PowerShares QQQ Trust Ser 1, sells Vanguard S&P 500 ETF, Vanguard Short-Term Corporate Bond ETF, Wells Fargo, Vanguard Small Cap ETF, Vanguard Large Cap ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Salomon & Ludwin, LLC.
E ratio of -2.31.
Estimates highest ever Breast Products yearly revenue of $80-$81 million representing 46%-47% full year growth Results driven by continued strong demand for Sientra Breast Products and commercial execution SANTA BARBARA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced preliminary unaudited financial results for the fourth quarter and full year ended December 31,
The U.S. plastic surgery market is thought to be worth around $13 billion. With its new acquisition, Sientra (SIEN) will be hoping to improve its positioning in this lucrative space. On Wednesday, the medical aesthetics company announced it plans on acquiring AuraGen’s fat grafting technology for $17.5 million. This consists of $13.5 million in stock, $1 million in cash when the deal closes, and another $3 million in cash in 12 months time. There’s a potential $8.5 million earnout too, subject to the achievement of certain clinical endpoints. While the product has yet to hit the market, it’s already FDA-approved and Sientra plans a full commercial launch in January 2023.
Colliers Securities analyst Kyle Bauser reiterated a Buy rating on Sientra (SIEN – Research Report) today and set a price target of $10.00. The company's shares closed last Wednesday at $3.41. According to TipRanks.com, Bauser is a 3-star analyst with an average return of 4.1% and a 44.7% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Chembio Diagnostics, Semler Scientific, and Motus Gi Holdings. Sientra has an analyst consensus of Moderate Buy, with a price target consensus of $11.50. See today’s best-performing stocks on TipRanks >> The company has a one-year high of $9.14 and a one-year low of $3.56.
Broadens Sientra’s opportunity within the estimated $13 billion U.S. plastic surgery market1 with the addition of a highly differentiated, FDA-cleared fat grafting technology Leverages Sientra’s existing commercial team and strong brand reputation to drive growth in breast augmentation and reconstruction marketExpands into new aesthetic applications – including the significant opportunity for face, hands and gluteal augmentation – with a clinically proven system that delivers superior retention
SANTA BARBARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that members of management will present at the upcoming H.C. Wainwright Bioconnect Virtual Conference. A Pre-recorded presentation will be available on Monday, January 10th at 7:00 am Eastern Time. Interested parties may access a webcast of the presentation on the invest
AWM Investment Company, Inc. Buys Destination XL Group Inc, LiqTech International Inc, Gambling. ...
New York, NY, based Investment company AWM Investment Company, Inc. (Current Portfolio) buys Destination XL Group Inc, LiqTech International Inc, Gambling.com Group, PLBY Group Inc, Veru Inc, sells , Generation Bio Co, American Public Education Inc, Ondas Holdings Inc, Medicenna Therapeutics Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, AWM Investment Company, Inc..
Royal Bank of Canada trimmed its position in shares of Sientra, Inc. (NASDAQ:SIEN) by 19.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,170 shares of the medical instruments supplier’s stock after selling 6,284 shares during the quarter. Royal Bank […]